Polat Aslıhan, Çakir Uğur, Gündüz Nermin
Department of Psychiatry, Kocaeli University School of Medicine, Kocaeli, Turkey.
Department of Psychiatry, Abant İzzet Baysal University School of Medicine, Bolu, Turkey.
Noro Psikiyatr Ars. 2016 Mar;53(1):87-88. doi: 10.5152/npa.2015.9855. Epub 2016 Mar 1.
Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in a 41-year-old woman.
氯氮平是一种非典型抗精神病药物,已被美国食品药品监督管理局(FDA)批准用于治疗精神障碍。粒细胞缺乏症是氯氮平已被确认的副作用;氯氮平也与其他血液系统疾病如白细胞增多有关,尽管这种情况很少见。在本文中,我们旨在报告一例41岁女性可能与氯氮平相关的白细胞增多病例。